NCT05355701 A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. Status RECRUITING Phase PHASE1
NCT05352685 Effects of Propofol on Auditory Event-related Potentials and Brain Functional Connectivity in Patients With Supratentorial Glioma Status RECRUITING Phase NA
NCT05345002 All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma Status RECRUITING Phase PHASE2
NCT05259605 Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification Status RECRUITING Phase N/A
NCT05188508 Pembrolizumab, Olaparib, and Temozolomide for People With Glioma Status RECRUITING Phase PHASE2
NCT05182905 AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05143788 Strategic Intervention on Preserving Motor Function During Awake Craniotomy Status UNKNOWN Phase NA
NCT05143775 Strategic Intervention on Preserving Language Function During Awake Craniotomy Status UNKNOWN Phase NA
NCT05140785 Mapping Molecular Markers of Brain Tumour Activity Using MRI Status NOT_YET_RECRUITING Phase NA
NCT05076513 Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05061251 Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma Status WITHDRAWN Phase EARLY_PHASE1
NCT05045027 Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1